| Dr Michael Joel Rivera Rios, MD | |
|
80 Seymour St, Hartford, CT 06102 | |
| (860) 224-5771 | |
| Not Available |
| Full Name | Dr Michael Joel Rivera Rios |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 5 Years |
| Location | 80 Seymour St, Hartford, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255872164 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Hospital Of Central Connecticut | New britain, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Hospital Of Central Connecticut At New Britain General And Bradley | 6507776564 | 321 |
News Archive
ProteaBio Europe SAS, a leading developer of new technology, announced today that the company has concluded an exclusive, worldwide license agreement with George Washington University for commercial rights to a new technology that provides rapid identification of a broad range of chemicals and biomolecules.
Scientists have used human stem cells to dramatically improve the condition of mice with a neurological condition similar to a set of diseases in children that are invariably fatal, according to an article in the June issue of the journal Cell Stem Cell.
Florida Medical Clinic (FMC), a multispecialty group practice, has selected the PDS PRISM to expand analytical and reporting capabilities.
Fixed dose combination (FDC) products, which have been around for many years, can have both clinical and commercial advantages. Successful FDC products require thoughtful planning, beginning early in the product development and lifecycle management processes.
› Verified 7 days ago
| Entity Name | Hartford Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407806391 PECOS PAC ID: 2567366016 Enrollment ID: O20031125000700 |
News Archive
ProteaBio Europe SAS, a leading developer of new technology, announced today that the company has concluded an exclusive, worldwide license agreement with George Washington University for commercial rights to a new technology that provides rapid identification of a broad range of chemicals and biomolecules.
Scientists have used human stem cells to dramatically improve the condition of mice with a neurological condition similar to a set of diseases in children that are invariably fatal, according to an article in the June issue of the journal Cell Stem Cell.
Florida Medical Clinic (FMC), a multispecialty group practice, has selected the PDS PRISM to expand analytical and reporting capabilities.
Fixed dose combination (FDC) products, which have been around for many years, can have both clinical and commercial advantages. Successful FDC products require thoughtful planning, beginning early in the product development and lifecycle management processes.
› Verified 7 days ago
| Entity Name | Hartford Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770696643 PECOS PAC ID: 2567366016 Enrollment ID: O20031125000752 |
News Archive
ProteaBio Europe SAS, a leading developer of new technology, announced today that the company has concluded an exclusive, worldwide license agreement with George Washington University for commercial rights to a new technology that provides rapid identification of a broad range of chemicals and biomolecules.
Scientists have used human stem cells to dramatically improve the condition of mice with a neurological condition similar to a set of diseases in children that are invariably fatal, according to an article in the June issue of the journal Cell Stem Cell.
Florida Medical Clinic (FMC), a multispecialty group practice, has selected the PDS PRISM to expand analytical and reporting capabilities.
Fixed dose combination (FDC) products, which have been around for many years, can have both clinical and commercial advantages. Successful FDC products require thoughtful planning, beginning early in the product development and lifecycle management processes.
› Verified 7 days ago
| Entity Name | The Hospital Of Central Connecticut At New Britain General And Bradley |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063461481 PECOS PAC ID: 6507776564 Enrollment ID: O20040115000497 |
News Archive
ProteaBio Europe SAS, a leading developer of new technology, announced today that the company has concluded an exclusive, worldwide license agreement with George Washington University for commercial rights to a new technology that provides rapid identification of a broad range of chemicals and biomolecules.
Scientists have used human stem cells to dramatically improve the condition of mice with a neurological condition similar to a set of diseases in children that are invariably fatal, according to an article in the June issue of the journal Cell Stem Cell.
Florida Medical Clinic (FMC), a multispecialty group practice, has selected the PDS PRISM to expand analytical and reporting capabilities.
Fixed dose combination (FDC) products, which have been around for many years, can have both clinical and commercial advantages. Successful FDC products require thoughtful planning, beginning early in the product development and lifecycle management processes.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Joel Rivera Rios, MD 20 Park St Apt 407, Hartford, CT 06106-5360 Ph: (787) 313-3345 | Dr Michael Joel Rivera Rios, MD 80 Seymour St, Hartford, CT 06102 Ph: (860) 224-5771 |
News Archive
ProteaBio Europe SAS, a leading developer of new technology, announced today that the company has concluded an exclusive, worldwide license agreement with George Washington University for commercial rights to a new technology that provides rapid identification of a broad range of chemicals and biomolecules.
Scientists have used human stem cells to dramatically improve the condition of mice with a neurological condition similar to a set of diseases in children that are invariably fatal, according to an article in the June issue of the journal Cell Stem Cell.
Florida Medical Clinic (FMC), a multispecialty group practice, has selected the PDS PRISM to expand analytical and reporting capabilities.
Fixed dose combination (FDC) products, which have been around for many years, can have both clinical and commercial advantages. Successful FDC products require thoughtful planning, beginning early in the product development and lifecycle management processes.
› Verified 7 days ago
Dr. Perry Maxwell Dansky, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 114 Woodland St, Saint Francis Hospital Emergency Department, Hartford, CT 06105 Phone: 860-714-4701 Fax: 860-714-8046 | |
Christina Jennifer Lu, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Seymour Street, Hartford Hospital Department Of Emergency Medicine, Hartford, CT 06102 Phone: 860-972-0001 Fax: 860-545-2274 | |
Dr. Jeffrey Peter Spear, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 114 Woodland St, Emergency Department, Hartford, CT 06105 Phone: 860-714-4001 Fax: 860-714-8046 | |
Jillian Smith, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 114 Woodland St, Dept Of Emergency Medicine, Hartford, CT 06105 Phone: 860-714-4001 | |
Michael W Joseph, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Seymour St, Hartford, CT 06102 Phone: 860-972-1448 Fax: 860-545-1461 | |
Lisa Michelle Samuelson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Seymour St, Hartford, CT 06102 Phone: 860-972-0001 | |
Dr. Rebecca Beth Apollon, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 114 Woodland St, Hartford, CT 06105 Phone: 860-714-4701 Fax: 860-714-8046 |